Supplementary Figure SF2 from Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial
Daniel Rodriguez Gutierrez(Nottingham University Hospitals NHS Trust), Tim Jaspan(Nottingham University Hospitals NHS Trust), Adela Cañete(Universitat de València), Chris Jones(North Carolina State University), Esther Sánchez Aliaga(Radboud University Nijmegen), Monika Warmuth‐Metz, Marie‐Cécile Le Deley(Institut Gustave Roussy), Josep Garcia(Roche (Switzerland)), Gudrun Zahlmann(Quantitative BioSciences), Raphaël Calmon(Hôpital Necker-Enfants Malades), Amedeo A. Azizi(Medical University of Vienna), Frank Saran(Institut Gustave Roussy), Jacques Grill(Institut Gustave Roussy), Daniel Warren(Johns Hopkins University), Gilles Vassal(Université Paris-Saclay), Alan Mackay(Institute of Cancer Research), Pascale Varlet(Inserm), Paul S. Morgan(Nottingham University Hospitals NHS Trust), Darren Hargrave(Great Ormond Street Hospital), Maura Massimino(Fondazione IRCCS Istituto Nazionale dei Tumori), Raphaël F. Rousseau
Cited by 0
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k